|
231 |
Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA) Clark, Virginia C.. - Aachen : Universitätsbibliothek der RWTH Aachen, 2024
|
|
|
232 |
Heresy, witchcraft, Jean Gerson, scepticism and the use of placebo controls Kirakosian, R.. - Heidelberg : Universitätsbibliothek Heidelberg, 2024
|
|
|
233 |
Less Pain with Intra-Articular Hyaluronic Acid Injections for Knee Osteoarthritis Compared to Placebo: A Systematic Review and Meta-Analysis of Randomised Controlled Trials Migliorini, Filippo. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2024
|
|
|
234 |
L. reuteri in Supportive Periodontal Therapy—Are There Already Clinical Effects after 3 Months with One Lozenge a Day? A Double-Blind Randomized Placebo-Controlled Study Thierbach, René. - Saarbrücken : Saarländische Universitäts- und Landesbibliothek, 2024
|
|
|
235 |
Magnetic Resonance Imaging Measures to Track Atrophy Progression in Progressive Supranuclear Palsy in Clinical Trials Quattrone, Andrea. - Ludwig-Maximilians-Universität München, 2024
|
|
|
236 |
Oxytocin and social learning in socially anxious men and women Flechsenhar, Aleyna. - Ludwig-Maximilians-Universität München, 2024
|
|
|
237 |
Peripheral Blood Leukocyte Subpopulation Changes in Reaction to an Acute Psychosocial Stressor as Compared to an Active Placebo-Stressor in Healthy Young Males : Mediating Effects of Major Stress-Reactive Endocrine Parameters Walther, Lisa-Marie. - Konstanz : KOPS Universität Konstanz, 2024
|
|
|
238 |
Protein Supplementation Increases Adaptations to Low-Volume, Intra-Session Concurrent Training in Untrained Healthy Adults: A Double-Blind, Placebo-Controlled, Randomized Trial Reljic, Dejan. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2024
|
|
|
239 |
Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson's disease (ROCK-PD) Wolff, Andreas W.. - Ludwig-Maximilians-Universität München, 2024
|
|
|
240 |
Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study Bavendiek, Udo. - Würzburg : Universität Würzburg, 2024
|
|